Akt2 deficiency promotes cardiac induction of Rab4a and myocardial β-adrenergic hypersensitivity

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 6, 2010, Pages 931-940

  Etzion, Sharon ^a   Etzion, Yoram ^a   Debosch, Brian ^a   Crawford, Peter A ^a   Muslin, Anthony J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenergic receptor; Cardiac hypertrophy; Cardiac metabolism; Diabetes mellitus; Insulin resistance

Indexed keywords

BETA ADRENERGIC RECEPTOR; FATTY ACID; FORSKOLIN; ISOPRENALINE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROPRANOLOL; PROTEIN KINASE B BETA; PROTEIN RAB4A; RAB PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; FATTY ACID OXIDATION; HEART CELL CULTURE; HEART VENTRICLE HYPERTROPHY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN ISOLATION; PROTEIN SYNTHESIS INHIBITION; RAT; UPREGULATION; WILD TYPE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARDIOMEGALY; CELLS, CULTURED; ENZYME INDUCTION; GENE EXPRESSION REGULATION; ISOPROTERENOL; MICE; MYOCARDIUM; MYOCYTES, CARDIAC; PPAR ALPHA; PROPRANOLOL; PROTO-ONCOGENE PROTEINS C-AKT; RAB4 GTP-BINDING PROTEINS; RATS; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; TIME FACTORS;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 78149406551     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.08.011     Document Type: Article

References (45)

1. Mazzone T., Chait A., Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet May 24 2008, 371(9626):1800-1809.
2. Cohen-Solal A., Beauvais F., Logeart D. Heart failure and diabetes mellitus: epidemiology and management of an alarming association. J Card Fail Sep 2008, 14(7):615-625.
3. Boudina S., Abel E.D. Diabetic cardiomyopathy revisited. Circulation Jun 26 2007, 115(25):3213-3223.
4. Zaid H., Antonescu C.N., Randhawa V.K., Klip A. Insulin action on glucose transporters through molecular switches, tracks and tethers. Biochem J Jul 15 2008, 413(2):201-215.
5. Cantley L.C. The phosphoinositide 3-kinase pathway. Science May 31 2002, 296(5573):1655-1657.
6. Farese R.V., Sajan M.P., Standaert M.L. Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes. Exp Biol Med (Maywood) Oct 2005, 230(9):593-605.
7. Lehman J.J., Kelly D.P. Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth. Heart Fail Rev Apr 2002, 7(2):175-185.
8. Yamada E., Okada S., Saito T., Ohshima K., Sato M., Tsuchiya T., et al. Akt2 phosphorylates Synip to regulate docking and fusion of GLUT4-containing vesicles. J Cell Biol Mar 14 2005, 168(6):921-928.
9. Sano H., Kane S., Sano E., Miinea C.P., Asara J.M., Lane W.S., et al. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem Apr 25 2003, 278(17):14599-14602.
10. Aledo J.C., Darakhshan F., Hundal H.S. Rab4, but not the transferrin receptor, is colocalized with GLUT4 in an insulin-sensitive intracellular compartment in rat skeletal muscle. Biochem Biophys Res Commun Oct 4 1995, 215(1):321-328.
11. Dransfeld O., Uphues I., Sasson S., Schurmann A., Joost H.G., Eckel J. Regulation of subcellular distribution of GLUT4 in cardiomyocytes: Rab4A reduces basal glucose transport and augments insulin responsiveness. Exp Clin Endocrinol Diabetes 2000, 108(1):26-36.
12. Burgering B.M. A brief introduction to FOXOlogy. Oncogene Apr 7 2008, 27(16):2258-2262.
13. Cho H., Thorvaldsen J.L., Chu Q., Feng F., Birnbaum M.J. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem Oct 19 2001, 276(42):38349-38352.
14. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw E.B., et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science Jun 1 2001, 292(5522):1728-1731.
15. George S., Rochford J.J., Wolfrum C., Gray S.L., Schinner S., Wilson J.C., et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science May 28 2004, 304(5675):1325-1328.
16. Sasso F.C., Torella D., Carbonara O., Ellison G.M., Torella M., Scardone M., et al. Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease. J Am Coll Cardiol Sep 6 2005, 46(5):827-834.
17. Debosch B., Sambandam N., Weinheimer C., Courtois M., Muslin A.J. Akt2 regulates cardiac metabolism and cardiomyocyte survival. J Biol Chem Oct 27 2006, 281(43):32841-32851.
18. Filipeanu C.M., Zhou F., Lam M.L., Kerut K.E., Claycomb W.C., Wu G. Enhancement of the recycling and activation of beta-adrenergic receptor by Rab4 GTPase in cardiac myocytes. J Biol Chem Apr 21 2006, 281(16):11097-11103.
19. Odley A., Hahn H.S., Lynch R.A., Marreez Y., Osinska H., Robbins J., et al. Regulation of cardiac contractility by Rab4-modulated beta2-adrenergic receptor recycling. Proc Natl Acad Sci U S A May 4 2004, 101(18):7082-7087.
20. Finck B.N., Lehman J.J., Leone T.C., Welch M.J., Bennett M.J., Kovacs A., et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest Jan 2002, 109(1):121-130.
21. Asai K., Yang G.P., Geng Y.J., Takagi G., Bishop S., Ishikawa Y., et al. Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse. J Clin Invest Sep 1999, 104(5):551-558.
22. Seachrist J.L., Anborgh P.H., Ferguson S.S. beta 2-adrenergic receptor internalization, endosomal sorting, and plasma membrane recycling are regulated by rab GTPases. J Biol Chem Sep 1 2000, 275(35):27221-27228.
23. Ni Y.G., Wang N., Cao D.J., Sachan N., Morris D.J., Gerard R.D., et al. FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. Proc Natl Acad Sci U S A Dec 18 2007, 104(51):20517-20522.
24. Metrich M., Lucas A., Gastineau M., Samuel J.L., Heymes C., Morel E., et al. Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ Res Apr 25 2008, 102(8):959-965.
25. Ulucan C., Wang X., Baljinnyam E., Bai Y., Okumura S., Sato M., et al. Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy. Am J Physiol Heart Circ Physiol Sep 2007, 293(3):H1662-H1672.
26. Park S.Y., Cho Y.R., Finck B.N., Kim H.J., Higashimori T., Hong E.G., et al. Cardiac-specific overexpression of peroxisome proliferator-activated receptor-alpha causes insulin resistance in heart and liver. Diabetes Sep 2005, 54(9):2514-2524.
27. Rockman H.A., Koch W.J., Lefkowitz R.J. Seven-transmembrane-spanning receptors and heart function. Nature Jan 10 2002, 415(6868):206-212.
28. Choi D.J., Koch W.J., Hunter J.J., Rockman H.A. Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase. J Biol Chem Jul 4 1997, 272(27):17223-17229.
29. Lohse M.J. Molecular mechanisms of membrane receptor desensitization. Biochim Biophys Acta Nov 7 1993, 1179(2):171-188.
30. Saadane N., Alpert L., Chalifour L.E. Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice. Br J Pharmacol Jul 1999, 127(5):1165-1176.
31. Hohimer A.R., Davis L.E., Hatton D.C. Repeated daily injections and osmotic pump infusion of isoproterenol cause similar increases in cardiac mass but have different effects on blood pressure. Can J Physiol Pharmacol Feb 2005, 83(2):191-197.
32. Kudej R.K., Iwase M., Uechi M., Vatner D.E., Oka N., Ishikawa Y., et al. Effects of chronic beta-adrenergic receptor stimulation in mice. J Mol Cell Cardiol Oct 1997, 29(10):2735-2746.
33. Faulx M.D., Ernsberger P., Vatner D., Hoffman R.D., Lewis W., Strachan R., et al. Strain-dependent beta-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice. Am J Physiol Heart Circ Physiol Jul 2005, 289(1):H30-H36.
34. Cormont M., Gautier N., Ilc K., le Marchand-Brustel Y. Expression of a prenylation-deficient Rab4 inhibits the GLUT4 translocation induced by active phosphatidylinositol 3-kinase and protein kinase B. Biochem J May 15 2001, 356(Pt 1):143-149.
35. Vollenweider P., Martin S.S., Haruta T., Morris A.J., Nelson J.G., Cormont M., et al. The small guanosine triphosphate-binding protein Rab4 is involved in insulin-induced GLUT4 translocation and actin filament rearrangement in 3T3-L1 cells. Endocrinology Nov 1997, 138(11):4941-4949.
36. Li X., Monks B., Ge Q., Birnbaum M.J. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator. Nature Jun 21 2007, 447(7147):1012-1016.
37. Harris I.S., Treskov I., Rowley M.W., Heximer S., Kaltenbronn K., Finck B.N., et al. G-protein signaling participates in the development of diabetic cardiomyopathy. Diabetes Dec 2004, 53(12):3082-3090.
38. Loichot C., Jesel L., Tesse A., Tabernero A., Schoonjans K., Roul G., et al. Deletion of peroxisome proliferator-activated receptor-alpha induces an alteration of cardiac functions. Am J Physiol Heart Circ Physiol Jul 2006, 291(1):H161-H166.
39. Dorn G.W., Liggett S.B. Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure. Mol Pharmacol Sep 2009, 76(3):466-480.
40. Liggett S.B., Cresci S., Kelly R.J., Syed F.M., Matkovich S.J., Hahn H.S., et al. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat Med May 2008, 14(5):510-517.
41. Landray M.J., Toescu V., Kendall M.J. The cardioprotective role of beta-blockers in patients with diabetes mellitus. J Clin Pharm Ther Aug 2002, 27(4):233-242.
42. Di Bari M., Marchionni N., Pahor M. Beta-blockers after acute myocardial infarction in elderly patients with diabetes mellitus: time to reassess. Drugs Aging 2003, 20(1):13-22.
43. Haas S.J., Vos T., Gilbert R.E., Krum H. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials. Am Heart J Nov 2003, 146(5):848-853.
44. Hata J.A., Williams M.L., Schroder J.N., Lima B., Keys J.R., Blaxall B.C., et al. Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading. J Card Fail Jun 2006, 12(5):360-368.
45. Iaccarino G., Barbato E., Cipolletta E., De Amicis V., Margulies K.B., Leosco D., et al. Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur Heart J Sep 2005, 26(17):1752-1758.